ABSTRACT
Description: HBVAXPRO is a recombinant vaccine against hepatitis B. It is a new formulation of recombinant hepatitis B vaccine without thiomersal. HBVAXPRO consists of the 24-kDa major surface antigen of the hepatitis B virus obtained by recombinant DNA technology. HBVAXPRO is presented in a prefilled syringe as a suspension for intramuscular injection.
